Financiere de Tubize SA

FTD

Company Profile

  • Business description

    Financiere de Tubize SA is a holding company that owns a stake in UCB, a biopharmaceutical company. UCB is a world-wide biotechnology company that develops treatments for conditions related to neurology and immunology. UCB generates the vast majority of its revenue in the United States, followed by Europe and other international markets. Majority of its sales revenue is derived from its neurology products, followed by its immunology products. The company's plan focuses on leveraging scientific advances and skills in areas such as genetics, biomarkers, and human biology.

  • Contact

    Allee de la Recherche, 60
    Brussels1070
    BEL

    T: +32 497515208

    https://www.financiere-tubize.be

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    250

Stocks News & Analysis

stocks

ASX listed gold miner under pressure due to lower production

Shares have dropped nearly 20% since lowering 2026 volume guidance.
stocks

3 ASX opportunities after earnings season

Uncovering key opportunities following February’s results.
stocks

Oracle earnings: Solid execution secures revenue target and mitigates investor concerns

We raise our fair value estimate for Oracle stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,838.905.400.06%
CAC 407,974.4938.520.49%
DAX 4023,730.92166.910.71%
Dow JONES (US)46,993.2646.850.10%
FTSE 10010,403.6085.910.83%
HKSE25,853.2615.28-0.06%
NASDAQ22,479.53105.350.47%
Nikkei 22554,898.441,198.052.23%
NZX 50 Index13,289.29107.060.81%
S&P 5006,716.0916.710.25%
S&P/ASX 2008,632.406.200.07%
SSE Composite Index4,037.1112.80-0.32%

Market Movers